Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes

Citation
Mj. Pongers-willemse et al., Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes, LEUKEMIA, 12(12), 1998, pp. 2006-2014
Citations number
46
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
LEUKEMIA
ISSN journal
08876924 → ACNP
Volume
12
Issue
12
Year of publication
1998
Pages
2006 - 2014
Database
ISI
SICI code
0887-6924(199812)12:12<2006:RQPFTD>2.0.ZU;2-8
Abstract
Analysis of minimal residual disease (MRD) can predict outcome in acute lym phoblastic leukemia (ALL). A large prospective study in childhood ALL has s hown that MRD analysis using immunoglobulin (Ig) and T cell receptor (TCR) gene rearrangements as PCR targets can identify good and poor prognosis gro ups of substantial size that might profit from treatment adaptation. This M RD-based risk group assignment was based on the kinetics of tumor reduction . Consequently, the level of MRD has to be defined precisely in follow-up s amples. However, current PCR methods do not allow easy and accurate quantif ication. We have tested 'real-time' quantitative PCR (RQ-PCR) using the Taq Man technology and compared its sensitivity with two conventional MRD-PCR m ethods, ie dot-blot and liquid hybridization of PCR amplified Ig/TCR gene r earrangements using clone-specific radioactive probes. In RQ-PCR the genera ted specific PCR product is measured at each cycle ('real-time') by cleavag e of a fluorogenic intrinsic TaqMan probe. The junctional regions of rearra nged Ig/TCR genes define the specificity and sensitivity of PCR-based MRD d etection in ALL and are generally used to design a patient-specific probe. In the TaqMan technology we have chosen for the same approach with the desi gn of patient-specific TaqMan probes at the position of the junctional regi ons. We developed primers/probe combinations for RQ-PCR analysis of a total of three IGH, two TCRD, two TCRG and three IGK gene rearrangements in four randomly chosen precursor-B-ALL. In one patient, 12 bone marrow follow-up samples were analyzed for the presence of MRD using an IGK PCR target. The sensitivity of the RQ-PCR technique appeared to be comparable to the dot-bl ot method, but less sensitive than liquid hybridization. Although it still is a relatively expensive method, RQ-PCR allows sensitive, reproducible and quantitative MRD detection with a high throughput of samples providing pos sibilities for semi-automation. We consider this novel technique as an impo rtant step forward towards routinely performed diagnostic MRD studies.